文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

单味中药对慢性肾脏病影响的新见解

New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease.

作者信息

Shao Minghai, Ye Chaoyang, Bayliss George, Zhuang Shougang

机构信息

Department of Nephrology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, United States.

出版信息

Front Pharmacol. 2021 Nov 4;12:774414. doi: 10.3389/fphar.2021.774414. eCollection 2021.


DOI:10.3389/fphar.2021.774414
PMID:34803715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8599578/
Abstract

The clinical and experimental study into the effects of Chinese herbal medicines on chronic kidney disease has evolved over the past 40 years with new insight into their mechanism and evidence of their clinical effects. Among the many traditional Chinese herbs examined in chronic renal disease, five were found to have evidence of sufficient clinical efficacy, high frequency of use, and well-studied mechanism. They are: and , and its components (tanshinone II A, salvianolic acid A and B); and its monomer ; and its components (triptolide, tripterygium glycosides); Kudzu root and its monomer . These Chinese herbal medications have pharmaceutical effects against fibrosis, inflammation and oxidative stress and also promote renal repair and regeneration. This article reviews their clinical efficacy, anti-fibrotic effects in animal models, and molecular mechanism of action.

摘要

在过去40年里,关于中草药对慢性肾脏病影响的临床和实验研究不断发展,对其作用机制有了新的认识,并积累了临床疗效证据。在众多用于慢性肾脏病研究的传统中草药中,有五种被发现具有充分的临床疗效证据、高使用频率以及深入研究的作用机制。它们是:[此处原文缺失具体草药名称]和[此处原文缺失具体草药名称];[此处原文缺失具体草药名称]及其成分(丹参酮IIA、丹酚酸A和B);[此处原文缺失具体草药名称]及其单体[此处原文缺失具体单体名称];[此处原文缺失具体草药名称]及其成分(雷公藤内酯醇、雷公藤多苷);葛根及其单体[此处原文缺失具体单体名称]。这些中草药具有抗纤维化、抗炎和抗氧化应激作用,还能促进肾脏修复和再生。本文综述了它们的临床疗效、在动物模型中的抗纤维化作用以及分子作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d74/8599578/37914df28b08/fphar-12-774414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d74/8599578/37914df28b08/fphar-12-774414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d74/8599578/37914df28b08/fphar-12-774414-g001.jpg

相似文献

[1]
New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease.

Front Pharmacol. 2021-11-4

[2]
Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.

Phytother Res. 2021-1

[3]
Renal protective effect and action mechanism of Huangkui capsule and its main five flavonoids.

J Ethnopharmacol. 2017-7-12

[4]
Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs.

J Ethnopharmacol. 2014-8-7

[5]
Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.

J Ethnopharmacol. 2015-9-15

[6]
Research progress in the quality evaluation of Salvia miltiorrhiza based on the association of 'morphological features - functional substances - pharmacological action - clinical efficacy'.

Heliyon. 2023-9-25

[7]
[Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].

Zhongguo Zhong Yao Za Zhi. 2012-8

[8]
Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.

Am J Kidney Dis. 2014-3-14

[9]
Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.

J Ethnopharmacol. 2016-8-2

[10]
Treatment of chronic kidney disease using a traditional Chinese medicine, Flos Abelmoschus manihot (Linnaeus) Medicus (Malvaceae).

Clin Exp Pharmacol Physiol. 2016-2

引用本文的文献

[1]
Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases.

Front Pharmacol. 2025-2-21

[2]
Advances in the pharmacological mechanisms of berberine in the treatment of fibrosis.

Front Pharmacol. 2024-9-20

[3]
Pharmacological Mechanism of Chinese Medicine in Systemic Lupus Erythematosus: A Narrative Review.

Chin J Integr Med. 2025-2

[4]
A new perspective on proteinuria and drug therapy for diabetic kidney disease.

Front Pharmacol. 2024-7-31

[5]
Puerarin-A Promising Flavonoid: Biosynthesis, Extraction Methods, Analytical Techniques, and Biological Effects.

Int J Mol Sci. 2024-5-10

[6]
Shen Shuai II recipe improves renal hypoxia to attenuate renal injury in 5/6 renal ablation/infarction rats and effect evaluation using blood oxygenation level-dependent functional magnetic resonance imaging.

Ren Fail. 2024-12

[7]
Therapeutic Effect of Natural Products and Dietary Supplements on Aflatoxin-Induced Nephropathy.

Int J Mol Sci. 2024-3-1

[8]
Baicalin inhibits the replication of the hepatitis B virus by targeting TRIM25.

J Tradit Complement Med. 2023-5-31

[9]
Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis.

Drug Des Devel Ther. 2023

[10]
Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidii Fructus in Treating Colorectal Cancer.

Comb Chem High Throughput Screen. 2024

本文引用的文献

[1]
Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease.

Front Pharmacol. 2021-3-29

[2]
Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis.

Drug Des Devel Ther. 2020

[3]
Salvianolic Acid B Protects Against Fatty Acid-Induced Renal Tubular Injury via Inhibition of Endoplasmic Reticulum Stress.

Front Pharmacol. 2020-12-15

[4]
Standard Puerarin Prevents Diabetic Renal Damage by Inhibiting miRNA-140-5p Expression.

Diabetes Metab Syndr Obes. 2020-10-23

[5]
Total Flavones of Remodels Gut Microbiota and Inhibits Microinflammation in Chronic Renal Failure Progression by Targeting Autophagy-Mediated Macrophage Polarization.

Front Pharmacol. 2020-9-30

[6]
Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of (L.) Medik. on Renal Fibrosis.

Drug Des Devel Ther. 2020

[7]
Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis.

Biosci Rep. 2020-11-27

[8]
Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.

Int Immunopharmacol. 2020-12

[9]
Andrade-Oliveira Salvianolic Acid B Modulates Caspase-1-Mediated Pyroptosis in Renal Ischemia-Reperfusion Injury Nrf2 Pathway.

Front Pharmacol. 2020-9-3

[10]
Lipophilic Extract and Tanshinone IIA Derived from Attenuate Uric Acid Nephropathy through Suppressing Oxidative Stress-Activated MAPK Pathways.

Am J Chin Med. 2020-9-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索